Literature DB >> 16848656

Mood and sleep in Parkinson's disease.

Leora L Borek1, Robert Kohn, Joseph H Friedman.   

Abstract

OBJECTIVE: To determine whether severity of depression and severity of anxiety were associated with particular types of sleep disturbance in patients with Parkinson's disease.
METHOD: 120 patients with a diagnosis of idiopathic Parkinson's disease were consecutively recruited from a movement disorders clinic from July 2004 to May 2005. Idiopathic Parkinson's disease was diagnosed by a board-certified neurologist (J.H.F) and defined by the presence of 3 of the 4 cardinal signs of Parkinson's disease: resting tremor, rigidity, bradykinesia, and postural instability. Patients were administered the Hamilton Rating Scale for Depression, Hamilton Rating Scale for Anxiety, Covi Anxiety Scale, Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale (ESS). Patients were assessed for nightmares and rapid eye movement (REM) sleep behavior disorder (RBD) using a structured questionnaire and dream log. Multivariate analyses evaluated whether severity of depression and severity of anxiety correlated with the sleep outcome measures (PSQI, ESS, nightmares, and RBD).
RESULTS: The mean +/- SD age of the patients was 71 +/- 10.8 years with a mean Parkinson's disease duration of 7.3 +/- 4.7 years. Thirty-eight percent were female, 41.7% had a psychiatric history, 53.3% had nightmares, and 30% had clinically defined RBD. Severity of depression and severity of anxiety significantly correlated with poor sleep quality, daytime somnolence, and nightmares. Severity of depression contributed significantly to the overall variance in poor sleep quality and nightmares. Severity of anxiety contributed significantly to the overall variance in daytime somnolence.
CONCLUSIONS: Depressive and anxiety symptoms were associated with sleep disturbances in patients with Parkinson's disease. It is important to examine for the presence of depression and anxiety in patients presenting with sleep disorders, as depression and anxiety impair quality of life and are treatable conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16848656     DOI: 10.4088/jcp.v67n0613

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  26 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

2.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

3.  The association between clinically relevant anxiety and other non-motor symptoms in Parkinson's disease.

Authors:  Si-Ming Jiang; Yong-Sheng Yuan; Qing Tong; Li Zhang; Qin-Rong Xu; Jian Ding; Ke-Zhong Zhang
Journal:  Neurol Sci       Date:  2015-07-08       Impact factor: 3.307

Review 4.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

5.  The impact of sleep and mood disorders on quality of life in Parkinson's disease patients.

Authors:  Eva Havlikova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Berrie Middel; Tatiana Dubayova; Zuzana Gdovinova; Johan W Groothoff
Journal:  J Neurol       Date:  2011-05-26       Impact factor: 4.849

Review 6.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

Review 7.  Sleep Disturbance, Cognitive Decline, and Dementia: A Review.

Authors:  Alexandra M V Wennberg; Mark N Wu; Paul B Rosenberg; Adam P Spira
Journal:  Semin Neurol       Date:  2017-08-24       Impact factor: 3.420

8.  The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

Authors:  Sonja Rutten; Chris Vriend; Ysbrand D van der Werf; Henk W Berendse; Daniel Weintraub; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2017-02-01       Impact factor: 4.891

9.  Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men.

Authors:  Yue Leng; Samuel M Goldman; Peggy M Cawthon; Katie L Stone; Sonia Ancoli-Israel; Kristine Yaffe
Journal:  Int J Epidemiol       Date:  2018-10-01       Impact factor: 7.196

10.  Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities.

Authors:  Seockhoon Chung; Nicolaas I Bohnen; Roger L Albin; Kirk A Frey; Martijn L T M Müller; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.